The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ultra-sensitive pan-cancer molecular residual disease assessment using whole-genome sequencing-based personalized ctDNA panel: Initial results from the MONSTAR-SCREEN-3 project.
 
Tadayoshi Hashimoto
Honoraria - Cytogen; Takata Pharmaceutical
 
Shin Kobayashi
No Relationships to Disclose
 
Eiji Oki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda
Research Funding - Guardant Health
 
Yoshiaki Nakamura
Consulting or Advisory Role - DAIICHI SANKYO Co., Ltd.; Exact Sciences; Gilead Sciences; Guardant Health Pte Ltd; Natera,Inc.; Premo Partners, Inc.; Roche Ltd./; Seagen,Inc.; Takeda
Speakers' Bureau - Becton Dickinson; CareNet,Inc.; Chugai Pharma; DAIICHI SANKYO Co., Ltd.; Eisai; Guardant Health Japan Corp.; Guardant Health Pte Ltd; Hisamitsu Pharmaceutical; Merck; Miyarisan pharmaceutical; MSD K.K; Taiho Pharmaceutical; Zeria Pharmaceutical
Research Funding - Chugai Pharma (Inst); DAIICHI SANKYO Co., Ltd. (Inst); Genomedia (Inst); Guardant Health (Inst); Guardant Health AMEA, Inc. (Inst); Roche (Inst); Seagen,Inc. (Inst); Tempus (Inst)
 
Takahiro Kinoshita
Honoraria - Astellas Pharma; Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Gunze; Intuitive Surgical; Johnson & Johnson; Kaken Pharmaceutical; Medtronic; MSD; Olympus Medical Systems; Ono Pharmaceutical; Smart hospital
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Daiichi Sankyo; Johnson & Johnson K.K; Medtronic; Olympus Medical Systems; Ono Pharmaceutical; Otsuka; Taiho Pharmaceutical; Tsumura & Co.
 
Norio Nonomura
Honoraria - Astellas Pharma; AstraZeneca; Asuka Seiyaku; Bayer; Bristol-Myers Squibb; Chugai Pharma; Eisai; Janssen; Kissei Pharmaceutical; Kyorin; MSD; Nippon Shinyaku; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Nippon Shinyaku (Inst)
 
Kazuto Matsuura
No Relationships to Disclose
 
Hidemichi Watari
Honoraria - AstraZeneca; Takeda
Research Funding - Chugai Pharma; Hokkaido Cancer Society; Hokkaido Welfare Federation of Agricultural Corporatives; Kaken Pharmaceutical; Mochida Pharmaceutical Co. Ltd.; Taiho Pharmaceutical
Other Relationship - T-PEC
 
Naoto Gotohda
No Relationships to Disclose
 
Takeo Fujita
No Relationships to Disclose
 
Hiroji Iwata
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; Pfizer; Sanofi
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Kenjiro Namikawa
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - MSD; Novartis
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Shingo Sakashita
No Relationships to Disclose
 
Yoshikatsu Koga
No Relationships to Disclose
 
Takao Fujisawa
Honoraria - Amelief; AstraZeneca; Merck Serono
 
Hideaki Bando
Honoraria - Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
 
Takayuki Yoshino
Honoraria - Chugai Pharma; Merck; MSD K.K.; Takeda
Consulting or Advisory Role - Sumitomo Corp.
Research Funding - Amgen (Inst); Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Eisai (Inst); FALCO biosystems Ltd. (Inst); Medical & Biological Laboratories Co., Ltd. (Inst); Merus (Inst); Molecular Health (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Jeff Jasper
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Katherine Taber
Employment - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Dale Muzzey
Employment - Myriad Genetics
Leadership - Myriad Genetics
Stock and Other Ownership Interests - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Patents related to the business of Myriad Genetics.